Mingfeng Lee - Publications

TLR7/9-mediated mucosal innate immune dysregulation in IgA nephropathy.

Journal: Frontiers in immunology

Published: March 30, 2026

Plasmacytoid dendritic cells modulate the production of mucosal IgA in IgA nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: March 15, 2025

Lessons from IgA Nephropathy Models.

Journal: International journal of molecular sciences

Published: September 20, 2024

Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis.

Journal: Clinical kidney journal

Published: May 03, 2023

The nucleotide-sensing Toll-Like Receptor 9/Toll-Like Receptor 7 system is a potential therapeutic target for IgA nephropathy.

Journal: Kidney international

Published: December 21, 2022

Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy.

Journal: Biomedicines

Published: October 31, 2022

cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy.

Journal: PloS one

Published: July 28, 2022

Clinical Significance of the Intensity of Glomerular Galactose-Deficient IgA1 Deposition in IgA Nephropathy.

Journal: Kidney international reports

Published: May 03, 2022

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy.

Journal: Journal of clinical medicine

Published: March 31, 2022

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy.

Journal: CEN case reports

Published: February 14, 2020